KK
PTCT icon

KLP Kapitalforvaltning’s PTC Therapeutics PTCT Stock Holding History

KLP Kapitalforvaltning’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.3M Hold
15,900
– – ﹤0.01% 992
2026
Q1 		$1.08M Buy
15,900
+700
+5% +$49.6K ﹤0.01% 988
2025
Q4 		$1.15M Sell
15,200
-300
-2% -$21.8K ﹤0.01% 963
2025
Q3 		$951K Buy
15,500
+1,200
+8% +$62.5K ﹤0.01% 1059
2025
Q2 		$698K Hold
14,300
– – ﹤0.01% 1173
2025
Q1 		$729K Hold
14,300
– – ﹤0.01% 1100
2024
Q4 		$646K Buy
+14,300
New +$612K ﹤0.01% 1216

Other funds holding PTCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

KLP Kapitalforvaltning's PTCT Position: Q2 2026 in Review

KLP Kapitalforvaltning held its PTC Therapeutics (PTCT) position steady in Q2 2026 at 15,900 shares worth $1.3M. The position accounts for ﹤0.01% of the portfolio, ranked #992.

KLP Kapitalforvaltning first reported a position in PTCT in Q4 2024 and has held it in 7 quarters since. 382 funds tracked by Wall St. Rank hold PTCT as of Q2 2026.

  • KLP Kapitalforvaltning held 15,900 shares of PTC Therapeutics worth $1.3M as of Q2 2026.
  • KLP Kapitalforvaltning left its PTC Therapeutics share count unchanged in Q2 2026.
  • PTC Therapeutics made up ﹤0.01% of KLP Kapitalforvaltning's portfolio in Q2 2026, its #992 holding.
  • KLP Kapitalforvaltning first reported a position in PTC Therapeutics in Q4 2024 and has held it in 7 quarters since.
  • 382 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2026.

Based on KLP Kapitalforvaltning's 13F filing for Q2 2026, filed 12 Aug 2026.